Belo Sun Receives Construction Licence for the Volta Grande Gold Project
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Boston Scientific (BSX) PT Raised to $26 at Oppenheimer Following Solid 4Q
February 3, 2017 9:47 AM ESTOppenheimer raised its price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.00) while maintaining a Perform rating following the company's 4Q report.
Analyst Steven Lichtman commented, "BSX delivered strong, broad-based sales growth in 4Q16 and continued solid operating margin expansion. Sales in the quarter... More
